Browsing by Subject Antimalarials

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 495  next >
WHO_CDS_MAL_2003.1095.pdf.jpg
Access to antimalarial medicines : improving the affordability and financing of artemisinin-based combination therapies
World Health Organization. Malaria Unit ( 2003 )
9789242502091_fre.pdf.jpg
Accès universel aux tests diagnostiques du paludisme : manuel pratique
Organisation mondiale de la Santé ( 2012 )
EB57_SR-14_spa.pdf.jpg
Acta resumida provisional de la décima cuarta sesión
Consejo Ejecutivo, 57 ( 1976 )
EB57_SR-13_spa.pdf.jpg
Acta resumida provisional de la décima tercera sesión
Consejo Ejecutivo, 57 ( 1976 )
EB57_SR-21_spa.pdf.jpg
Acta resumida provisional de la vigésima primera sesión
Consejo Ejecutivo, 57 ( 1976 )
WHO_MAL_71_fre.pdf.jpg
L' action de la métachloridine, du proguanil (paludrine) et de la chloroquine intramusculaire sur les infections à Plasmodium Malariae : sommaire et conclusions / par Sol B. McLendon, Martin D. Young
McLendon, Sol B; Young, Martin D; WHO Expert Committee on Malaria ( 1951 )
A63_DIV6-en.pdf.jpg
Address by Mr Ray Chambers United Nations Secretary-General’s Special Envoy for Malaria to the Sixty-third World Health Assembly
World Health Assembly, 63 ( 2010 )
WHO_TRS_711_(part1).pdf.jpg
Advances in malaria chemotherapy : report of a WHO scientific group [meeting held in Geneva from 12 to 16 September 1983]
WHO Scientific Group on the Chemotherapy of Malaria; World Health Organization ( 1984 )
WHO_CDS_MAL_2003.1093.pdf.jpg
The Africa malaria report 2003
World Health Organization. Malaria Control Unit; UNICEF ( 2003 )
WHO_Mal_260.pdf.jpg
Aftermath of a field trial in self-administered pyrimethamine in a Ghanaian Community : the appearance of P. Falciparum resistance / by L. J. Charles
Charles, L. J; World Health Organization ( 1960 )
A63_DIV6-fr.pdf.jpg
Allocution de M. Ray Chambers, envoyé spécial du Secrétaire général de l’Organisation des Nations Unies pour le paludisme, à la Soixante-Troisième Assemblée mondiale de la Santé
Assemblée mondiale de la Santé, 63 ( 2010 )
A63_DIV6-sp.pdf.jpg
Alocución del Sr. Ray Chambers, Enviado Especial del Secretario General de las Naciones Unidas para la lucha contra la malaria, a la 63.a Asamblea Mundial de la Salud
Asamblea Mundial de la Salud, 63 ( 2010 )
Amodiaquine : a case for reconsideration? : reports on individual drugs
( 1996 )
RA_1999_1_37-44_fre.pdf.jpg
Analyse coût-efficacité de l' utilisation de l' artésunate et de la quinine + tétracycline pour le traitement du paludisme à falciparum non compliqué à Chanthaburi (Thaïland) / E. R. Honrado ... [et al.]
Honrado, E. R; Fungladda, W; Kamoiratanaku, P; Kitayaporn, D; Karbwang, J; Thimasarn, K; Masngammueng, R ( 1999 )
Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality / Paul D. Prinsen Geerligs, Bernard J. Brabin and Teunis A. Eggelte
Prinsen Geerligs, Paul D; Brabin, Bernard, J; Eggelte, Teunis A ( 2003 )
WHO_CDS_RBM_2001.35.pdf.jpg
Antimalarial drug combination therapy : report of a WHO technical consultation, 4-5 April 2001
Global Partnership to Roll Back Malaria ( 2001 )
Antimalarial drug development in China / editor, Shen Jiaxiang
Scientific Working Group on the Chemotherapy of Malaria. Meeting (1989: Beijing, China); Shen, Jiaxiang; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases ( 1990 )
WHO_MAL_94.1070.pdf.jpg
Antimalarial drug policies : data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy, report of an informal consultation, Geneva, 14-18 March 1994
World Health Organization. Division of Control of Tropical Diseases ( 1994 )
9_4_2003_492_508.pdf.jpg
Antimalarial drug resistance in the Eastern Mediterranean Region
Abdel Hameed, A.A. ( 2003 )
Abstract

Studies done between 1997 and 2003 are reviewed to give an overall picture of antimalarial drug resistance in the Eastern Mediterranean Region of the World Health Organization [WHO]. The situation in 8 countries where resistance has been reported is detailed. It has been difficult to abandon chloroquine as first-line treatment even though resistance to it is widespread. Resistance to sulfadoxine-pyrimethamine has also been detected. The spread of resistance could be slowed down by the adoption of effective national policies and control programmes. Coordination between counties and with other WHO regions, as opposed to working in isolation, could further reduce the spread of resistance

bulletin_1993_71(6)_763-772.pdf.jpg
Antimalarial drug utilization by women in Ethiopia : a knowledge-attitudes-practice study / H. Yeneneh ... [et al.]
Yeneneh, H; Gyorkos, Theresa W; Joseph, L; Pickering, J; Tedla, Shibru ( 1993 )
Showing results 1 to 20 of 495  next >